Report cover image

U.S. Artificial Ventilation And Anesthesia Masks Market Size, Share, Trends & Industry Analysis Report: By Mask (Disposable Masks and Reusable Masks), and By Application, – Market Forecast, 2025–2034

Published Jul 01, 2025
Length 130 Pages
SKU # PLRS20324340

Description

The global U.S. Artificial ventilation and Anesthesia Masks Market size is expected to reach USD 837.72 Million by 2034, according to a new study by Polaris Market Research. The report “U.S. Artificial Ventilation and Anesthesia Masks Market Size, Share, Trends & Industry Analysis Report: By Mask (Disposable Masks and Reusable Masks), and By Application, – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Artificial ventilation and anesthesia masks are vital medical tools designed to deliver controlled amounts of oxygen and anesthetic gases to patients. These masks also help remove carbon dioxide from the respiratory system. They are crucial for maintaining proper breathing during surgical procedures, managing respiratory distress in emergencies, and providing long-term support for individuals with chronic breathing conditions. Their diverse designs cater to various patient needs and healthcare settings, ensuring efficient and safe respiratory care.

The U.S. artificial ventilation and anesthesia masks market is experiencing steady growth driven by several factors. The rising number of surgical procedures, coupled with an increasing elderly population that often requires medical intervention, significantly boosts the demand for these masks. Furthermore, the growing occurrence of chronic respiratory diseases, such as COPD and sleep apnea, also plays a key role in expanding this market as more people need assisted breathing solutions. Technological advancements and a greater focus on patient safety also continue to shape the industry and its product developments.

U.S. artificial ventilation and anesthesia masks Market Report Highlights:

By mask, in the U.S., disposable masks held the largest share of the market in 2024. This dominance is due to their significant advantages in infection control, ease of use, and overall cost-effectiveness for healthcare facilities by eliminating the need for sterilization processes.

By application, the operating rooms segment held the largest share in the 2024 application segment. This is driven by the consistent and high volume of surgical procedures performed, where both anesthesia delivery and respiratory support masks are routinely and critically utilized for patient safety and successful surgical outcomes.

Key players in the market include Koninklijke Philips N.V., Medtronic PLC, ResMed Inc., Drägerwerk AG & Co. KGaA, Getinge AB, Fisher & Paykel Healthcare Corporation Limited, Ambu A/S, Vyaire Medical Inc., Flexicare Medical Limited, Hamilton Medical AG, and Cardinal Health Inc.

Polaris Market Research has segmented the U.S. artificial ventilation and anesthesia masks market report based on mask and application:

By Mask Outlook (Revenue – USD Million, 2020–2034)

Disposable Masks

Reusable Masks

By Application Outlook (Revenue – USD Million, 2020–2034)

Operating Rooms

ICU

Emergency Rooms

Homecare

ASCs

Table of Contents

130 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. Artificial Ventilation And Anesthesia Masks Market Insights
4.1. U.S. Artificial Ventilation And Anesthesia Masks Market – Market Snapshot
4.2. U.S. Artificial Ventilation And Anesthesia Masks Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Growing Number of Surgical Procedures
4.2.1.2. Rising Prevalence of Chronic Respiratory Diseases
4.2.2. Restraints and Challenges
4.2.2.1. Stringent regulatory compliance and associated delays
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Artificial Ventilation And Anesthesia Masks Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. U.S. Artificial Ventilation And Anesthesia Masks Market, by Mask
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020–2034 (USD Million)
5.3. Disposable Masks
5.3.1. U.S. Artificial Ventilation And Anesthesia Masks Market, by Disposable Masks, by Region, 2020–2034 (USD Million)
5.4. Reusable Masks
5.4.1. U.S. Artificial Ventilation And Anesthesia Masks Market, by Reusable Masks, by Region, 2020–2034 (USD Million)
6. U.S. Artificial Ventilation And Anesthesia Masks Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Artificial Ventilation And Anesthesia Masks Market, by Application, 2020–2034 (USD Million)
6.3. Operating Rooms
6.3.1. U.S. Artificial Ventilation And Anesthesia Masks Market, by Operating Rooms, by Region, 2020–2034 (USD Million)
6.4. ICU
6.4.1. U.S. Artificial Ventilation And Anesthesia Masks Market, by ICU, by Region, 2020–2034 (USD Million)
6.5. Emergency Rooms
6.5.1. U.S. Artificial Ventilation And Anesthesia Masks Market, by Emergency Rooms, by Region, 2020–2034 (USD Million)
6.6. Homecare
6.6.1. U.S. Artificial Ventilation And Anesthesia Masks Market, by Homecare, by Region, 2020–2034 (USD Million)
6.7. ASCs
6.7.1. U.S. Artificial Ventilation And Anesthesia Masks Market, by ASCs, by Region, 2020–2034 (USD Million)
7. Competitive Landscape
7.1. Expansion and Acquisition Analysis
7.1.1. Expansion
7.1.2. Acquisitions
7.2. Partnerships/Collaborations/Agreements/Exhibitions
8. Company Profiles
8.1. Ambu A/S
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Recent Development
8.2. Cardinal Health Inc.
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Recent Development
8.3. Drägerwerk AG & Co. KGaA
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Recent Development
8.4. Fisher & Paykel Healthcare Corporation Limited
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Recent Development
8.5. Flexicare Medical Limited
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Recent Development
8.6. Getinge AB
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Recent Development
8.7. Hamilton Medical AG (Hamilton Company)
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Recent Development
8.8. Koninklijke Philips N.V. (Philips Healthcare)
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Recent Development
8.9. Medtronic PLC
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Recent Development
8.10. ResMed Inc.
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Recent Development
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.